Lifecore Biomedical, Inc. (LFCR) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-08
3:52 pm
Sale
2022-02-1413GLIFECORE BIOMEDICAL INC
LFCR
DIMENSIONAL FUND ADVISORS LP1,973,608
6.700%
-245,753decrease
(-11.07%)
Filing
History
2022-02-01
5:08 pm
Sale
2021-12-3113GLIFECORE BIOMEDICAL INC
LFCR
BlackRock Inc.
BLK
1,946,458
6.600%
-144,572decrease
(-6.91%)
Filing
History
2022-01-20
4:16 pm
Purchase
2022-01-1213DLIFECORE BIOMEDICAL INC
LFCR
Wynnefield Partners Small Cap Value, L.P. I3,577,705
12.100%
387,400increase
(+12.14%)
Filing
History
2021-08-30
5:07 pm
Purchase
2021-08-2613DLIFECORE BIOMEDICAL INC
LFCR
Legion Partners Asset Management, LLC2,928,090
9.940%
23,750increase
(+0.82%)
Filing
History
Goto Prev, 0, 1, 2